Xylem/$XYL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Xylem

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.

Ticker

$XYL

Primary listing

NYSE

Industry

Machinery

Employees

23,000

ISIN

US98419M1009

Xylem Metrics

BasicAdvanced
$30B
33.74
$3.71
1.10
$1.48
1.28%

What the Analysts think about Xylem

Analyst ratings (Buy, Hold, Sell) for Xylem stock.

Bulls say / Bears say

Xylem's recent acquisition of Evoqua Water Technologies is expected to enhance its market position and drive revenue growth through expanded service offerings. (businesswire.com)
Analysts have set an average 12-month price target of $145.56 for Xylem, indicating a potential upside of approximately 20.85% from the current price. (stockanalysis.com)
Xylem's consistent dividend increases, including a recent quarterly dividend of $0.40 per share, reflect strong financial health and commitment to shareholder returns. (marketbeat.com)
Spruce Point Capital Management issued a 'Strong Sell' opinion on Xylem, citing concerns about the company's ability to meet aggressive growth expectations post-Evoqua acquisition. (businesswire.com)
Xylem's net margin of 14.45% falls below industry averages, indicating potential challenges in achieving strong profitability. (benzinga.com)
The company's return on equity (ROE) of 3.07% lags behind industry averages, suggesting difficulties in maximizing returns on equity capital. (benzinga.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jun 2025.

Xylem Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Xylem Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XYL

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jun26
Xylem
Dividend·Payment
$0.40Per share
FAQs